Back
Cardiff Oncology Vs. Perspective Therapeutics Industry Stock Comparison
Sell
45
CRDF
Cardiff Oncology
Last Price:
3.64
Seasonality Move:
40.21%
Buy
52
CATX
Perspective Therapeutics
Last Price:
1.60
Seasonality Move:
2.9%
Sell
45
Cardiff Oncology (CRDF)
is a Sell
Is Cardiff Oncology a Buy, Sell or Hold?
- The current Cardiff Oncology [CRDF] share price is $3.63. The Score for CRDF is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRDF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.60. The Score for CATX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRDF Stock Price Chart
What is Cardiff Oncology's stock price today?
-
The Cardiff Oncology share price today is $3.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDF is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.60
The current trend is moderately bearish and CATX is experiencing slight buying pressure.
CRDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 42.24 | Sell |
| Chaikin Money Flow: | -387457 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.48 - 4.5) | Sell |
| Bollinger Bands (100): | (1.65 - 4.83) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.53 - 1.77) | Sell |
| Bollinger Bands (100): | (0.67 - 1.53) | Buy |
CRDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.5 | Buy |
| 20-day SMA: | 3.83 | Sell |
| 50-day SMA: | 4.66 | Sell |
| 200-day SMA: | 2.34 | Buy |
| 8-day EMA: | 3.61 | Buy |
| 20-day EMA: | 3.86 | Sell |
| 50-day EMA: | 3.98 | Sell |
| 200-day EMA: | 2.81 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Sell |
| 20-day SMA: | 1.69 | Sell |
| 50-day SMA: | 1.47 | Buy |
| 200-day SMA: | 0.71 | Buy |
| 8-day EMA: | 1.66 | Sell |
| 20-day EMA: | 1.65 | Sell |
| 50-day EMA: | 1.46 | Buy |
| 200-day EMA: | 0.91 | Buy |
Cardiff Oncology Earnings Growth & CRDF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.17 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cardiff Oncology Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||